JPMorgan Adjusts XPENG-W Price Target to HK$118, Keeps Overweight Rating

Stock News
06/01

JPMorgan has updated its research report on XPENG-W (HKEX: 09868), revising its 2026 loss forecast to RMB 3.92 billion from a previous estimate of RMB 3.891 billion. The adjusted loss projection is set at RMB 3.47 billion, reflecting the company's first-quarter performance. Consequently, the bank has lowered its target price from HK$135 to HK$118.

The report notes that XPENG's Q1 results were largely in line with expectations. JPMorgan maintains a positive outlook on the company, anticipating an acceleration in sales growth starting from the second quarter. Additionally, expansion in overseas markets and developments related to artificial intelligence are expected to support a long-term potential revaluation of the stock. The firm reaffirms its "Overweight" rating.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10